Adaptive Trial Design Under the New FDA Framework: Integrating ICH E20, Bayesian Methods, and Trial Innovation
Author
Dr. Mukesh Kumar
Founder & CEO, FDAMap
FDA Purán Newsletter Signup
Subscribe to FDA Purán Newsletter for
Refreshing Outlook on Regulatory Topics
